Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Nelfinavir (AG1341) is an antiretroviral drug used in the treatment of the human immunodeficiency virus (HIV) (Ki=2 nM). Nelfinavir is a broad-spectrum, anticancer agent.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 36.00 | |
2 mg | In stock | $ 51.00 | |
5 mg | In stock | $ 80.00 | |
10 mg | In stock | $ 113.00 | |
25 mg | In stock | $ 177.00 | |
50 mg | In stock | $ 228.00 | |
100 mg | In stock | $ 300.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 98.00 |
Description | Nelfinavir (AG1341) is an antiretroviral drug used in the treatment of the human immunodeficiency virus (HIV) (Ki=2 nM). Nelfinavir is a broad-spectrum, anticancer agent. |
Targets&IC50 | HIV:2 nM (ki) |
In vitro | Nelfinavir decreased the viability of a panel of drug-resistant breast cancer cell lines and inhibited the growth of NSCLC xenografts that was associated with induction of ER stress, autophagy, and apoptosis. Nelfinavir is a lead HIV protease inhibitor with pleiotropic effects in cancer cells[1] |
Synonyms | AG1341 |
Molecular Weight | 567.78 |
Formula | C32H45N3O4S |
CAS No. | 159989-64-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (176.12 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Nelfinavir 159989-64-7 Microbiology/Virology Proteases/Proteasome HIV Protease production Human immunodeficiency virus AG 1341 protease myeloma inhibit phosphorylation cells AG1341 multiple AG-1341 Inhibitor proliferation HIV infection inhibitor